Literature DB >> 401727

Drug interactions with oral sulphonylurea hypoglycaemic drugs.

J M Hansen, L K Christensen.   

Abstract

The effect of the oral sulphonylurea hypoglycaemic drugs may be influenced by a large number of other drugs. Some of these combinations (e.g. phenylbutazone, sulphaphenazole) may result in cases of severe hypoglycaemic collapse. Tolbutamide and chlorpropamide should never be given to a patient without a prior careful check of which medicaments are already being given. Similarly, no drug should be given to a diabetic treated with tolbutamide and chlorpropamide without consideration of the possibility of interaction phenomena.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401727     DOI: 10.2165/00003495-197713010-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  63 in total

1.  HYPOGLYCEMIA WITH SALICYLATE POISONING. A REPORT OF TWO CASES.

Authors:  E K COTTON; V I FAHLBERG
Journal:  Am J Dis Child       Date:  1964-08

2.  HYPOGLYCEMIA IN TOLBUTAMIDE-TREATED DIABETES; REPORT OF TWO CASES WITH MEASUREMENT OF SERUM INSULIN.

Authors:  J S SOELDNER; J STEINKE
Journal:  JAMA       Date:  1965-08-02       Impact factor: 56.272

3.  Tolbutamide-induced hypoglycemia in Parkinson's disease; a case report.

Authors:  J F SCHWARTZ
Journal:  JAMA       Date:  1961-04-15       Impact factor: 56.272

4.  A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas.

Authors:  J M STOWERS; L W CONSTABLE; R B HUNTER
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

5.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

6.  Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects.

Authors:  H M Solomon; J J Schrogie
Journal:  Metabolism       Date:  1967-11       Impact factor: 8.694

7.  [HB 419, a new oral antidiabetic; administration to the aged].

Authors:  S Hirn; R P Königstein
Journal:  Wien Med Wochenschr       Date:  1969-09-20

8.  [Chlorpropamide-phenylbutazone as the cause of hypoglycemia. A case of an unfortunate drug combination].

Authors:  P E Thomsen; H O Ostenfeld; M Kristensen
Journal:  Ugeskr Laeger       Date:  1970-09-10

9.  Sulfonamide-sulfonylurea interaction.

Authors:  H S Tucker; J I Hirsch
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

10.  The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.

Authors:  T L Svendsen; M B Kristensen; J M Hansen; L Skovsted
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

View more
  25 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 3.  Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Stowers; L J Borthwick
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

Review 4.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

5.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.

Authors:  H S Purba; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects?

Authors:  T Richardson; J Foster; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

9.  Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Ranko Skrbic; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Arch Drug Inf       Date:  2008-07

10.  Glibenclamide-associated hypoglycaemia: a report on 57 cases.

Authors:  K Asplund; B E Wiholm; F Lithner
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.